Yes, it is being studied both as monotherapy and in combination with GLP-1 drugs
Theo nghin cu, s dng Glutathione thng qua ng ung gip gim ng k cc ch s melanin trong vng t nht l hai tun v lm sng mu da
Lessons From GLP-1/Glucagon Co-Agonists in Clinical Development The first GLP-1/glucagon co-agonist to advance to human clinical trials was cotadutide (MEDI0832)
The difference, I believe, is others give an explanation of the test
Assists in reducing hyperpigmentation and dark spots
Ultra-accelerated injury repair dramatically speeds healing of muscle tears, tendinitis, sprains and ligament damage, slashing post-surgery and post-training recovery times Digestive system healing (leaky gut) brutal cytoprotective properties repair stomach and intestinal walls, making it a key ally against leaky gut syndrome, gastric reflux, ulcers and IBD (Crohn's, colitis) Joint and bone health promotes bone healing, bone density and cartilage health in worn joints, going far beyond soft-tissue repair Nervous system and organ protection helps protect the liver against toxins (including alcohol) and promotes neuroprotection, balancing neurotransmitters and modulating brain inflammation Gastric-origin advantage derived from gastric juice, it carries innate cytoprotective properties that simultaneously protect the stomach lining while healing the rest of the body Technical sheet
